alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 447.53 Cost sharing for drugs.

(a) The agency may establish differential cost sharing for preferred and non-preferred drugs. The provisions in [§ 447.56(a)](/on/2024-09-17/title-42/section-447.56#p-447.56(a)) shall apply except as the agency exercises the option under [paragraph (d)](/on/2024-09-17/title-42/section-447.53#p-447.53(d)) of this section. All drugs will be considered preferred drugs if so identified or if the agency does not differentiate between preferred and non-preferred drugs.

(b) At state option, cost sharing for drugs may be established at or below the amounts shown in the following table (except that the maximum allowable cost sharing shall be increased each year, beginning October 1, 2015, by the percentage increase in the medical care component of the CPI-U for the period of September to September of the preceding calendar year, rounded to the next higher 5-cent increment. Such increase shall not be applied to any cost sharing that is based on the amount the agency pays for the service):

| Services | Maximum allowable cost sharing | |
| --- | --- | --- |
| Individuals with family income ≤150% of the FPL | Individuals with family income >150% of the FPL |
| Preferred Drugs | $4 | $4. |
| Non-Preferred Drugs | 8 | 20% of the cost the agency pays. |

(c) In states that do not have fee-for-service payment rates, cost sharing for prescription drugs imposed on individuals at any income level may not exceed the maximum amount established for individuals with income at or below 150 percent of the FPL in [paragraph (b)](/on/2024-09-17/title-42/section-447.53#p-447.53(b)) of this section.

(d) For individuals otherwise exempt from cost sharing under [§ 447.56(a)](/on/2024-09-17/title-42/section-447.56#p-447.56(a)), the agency may impose cost sharing for non-preferred drugs, not to exceed the maximum amount established in [paragraph (b)](/on/2024-09-17/title-42/section-447.53#p-447.53(b)) of this section.

(e) In the case of a drug that is identified by the agency as a non-preferred drug within a therapeutically equivalent or therapeutically similar class of drugs, the agency must have a timely process in place so that cost sharing is limited to the amount imposed for a preferred drug if the individual's prescribing provider determines that a preferred drug for treatment of the same condition either will be less effective for the individual, will have adverse effects for the individual, or both. In such cases the agency must ensure that reimbursement to the pharmacy is based on the appropriate cost sharing amount.
HomeCombating Drugs and Crime...Combating Drugs and Crime

# Combating Drugs and Crime

78 items

        -    Transnational Organized Crime Rewards Program  		Jermaine Stephenson	  November 7, 2022 
        -    Press Statement  		U.S. Department of State Announces Reward Offers for Information Leading to the Arrests and/or Convictions of Three Haitian Gang Leaders	  Antony J. BlinkenNovember 7, 2022 
        -    Remarks  		Remarks at a Joint Press Availability	  Antony J. BlinkenOctober 13, 2022Dean Acheson AuditoriumWashington, DC 
        -    Remarks  		Remarks at the U.S.-Mexico High-Level Security Dialogue	  Antony J. BlinkenOctober 13, 2022Loy Henderson AuditoriumWashington, DC 
        -    Transnational Organized Crime Rewards Program  		Badru Abdul Aziz Saleh	  May 26, 2022 
        -    Transnational Organized Crime Rewards Program  		Abdi Hussein Ahmed	  May 26, 2022 
        -    Transnational Organized Crime Rewards Program  		Reward for Information: Owners/Operators/Affiliates of the Conti Ransomware as a Service (RaaS)	  May 6, 2022 
        -    Transnational Organized Crime Rewards Program  		Christopher Vincent Kinahan, Sr.	  April 12, 2022 
        -    Transnational Organized Crime Rewards Program  		Christopher Kinahan, Jr.	  April 12, 2022 
        -    Transnational Organized Crime Rewards Program  		Daniel Joseph Kinahan	  April 12, 2022 

previous page1…345678next page

Back to Top
§ 59.4 How does one apply for a family planning services grant? ( a ) Application for a grant under this subpart shall be made on an authorized form.
( b ) An individual authorized to act for the applicant and to assume on behalf of the applicant the obligations imposed by the terms and conditions of the grant, including the regulations of this subpart, must sign the application.
( c ) The application shall contain ( 1 ) A description, satisfactory to the Secretary, of the project and how it will meet the requirements of this subpart;
( 2 ) A budget and justification of the amount of grant funds requested;
( 3 ) A description of the standards and qualifications which will be required for all personnel and for all facilities to be used by the project; and
( 4 ) Such other pertinent information as the Secretary may require.
Certification 
 

I, Ann Murtlow, certify that:

1. I have reviewed this quarterly report on Form 10-Q of IPALCO Enterprises, Inc. (the"registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport; 

3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control over financialreporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant's auditors and the auditcommittee of registrant's board of directors (or persons performing the equivalentfunction):

(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant'sability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant's internal control over financial reporting.

Date:	August 22, 2005	
	/s/ Ann Murtlow	
Ann MurtlowPresident and Chief Executive Officer
exhibit10-26.htm


    EXHIBIT
10.26

    


    PEOPLES
BANCORP INC. ANNUAL REPORT ON FORM 10-K

    FOR
FISCAL YEAR ENDED DECEMBER 31, 2008

    


    SUMMARY
OF BASE SALARIES FOR EXECUTIVE OFFICERS

    OF PEOPLES BANCORP
INC.

    


    The base
salaries of executive officers of Peoples Bancorp Inc. (“Peoples”) are
determined by evaluating the most recent comparative peer data and the role and
responsibilities of their positions.  Individual salary increases are
reviewed annually and are based on Peoples’ overall performance and the
executive’s attainment of specific individual business objectives during the
preceding year.

    


    The
following table details the base salaries to paid by Peoples and its
subsidiaries to Mark F. Bradley, President and Chief Executive Officer of
Peoples, and the four other most highly compensated executive officers of
Peoples for the fiscal year ending December 31, 2009:

    


    
      	
              Name

            	
              Position/Title

            	
              Base
      Salary

            
	
              Mark
      F. Bradley

            	
              President
      and Chief Executive Officer

            	
              $
      280,000

            
	 
      	 
      	 
      
	
              Carol
      A. Schneeberger

            	
              Executive
      Vice President, Operations

            	
              190,000

            
	 
      	 
      	 
      
	
              Joseph
      S. Yazombek

            	
              Executive
      Vice President – Chief Lending Officer

            	
              220,000

            
	 
      	 
      	 
      
	
              David
      T. Wesel

            	
              Executive
      Vice President, Investment and Insurance Services

            	
              180,000

            
	 
      	 
      	 
      
	
              Edward
      G. Sloane

            	
              Executive
      Vice President, Chief Financial Officer and Treasurer

            	
              196,000
1 Local Rule 47.5 provides: "The publication of opinions

that have no precedential value and merely decide particular cases
on the basis of well-settled principles of law imposes needless
expense on the public and burdens on the legal profession." Pursuant to that Rule, the court has determined that this opinion should not be published. UNITED STATES COURT OF APPEALS for the Fifth Circuit

_____________________________________

No. 95-50253 Summary Calendar

_____________________________________

BILLY DALE CARTER, BILLY FRANK DAVIS, and MOSES PRINCE, JR.,

Plaintiffs-Appellants

VERSUS

JOE GONZALES, WARDEN, ET AL,

Defendants-Appellees.

______________________________________________________ Appeal from the United States District Court for the Western District of Louisiana

(SA-94-CV-987)

______________________________________________________ November 13, 1995

Before DAVIS, BARKSDALE and DeMOSS, Circuit Judges.

PER CURIAM: 1

The only issue before this court is the propriety of the

district court's order denying injunctive relief to plaintiffs.

Inmates Billy Dale Carter, Billy Frank Davis, and Moses Prince sued

several officials of the Dolph Briscoe Unit of the Texas prison

system. Plaintiffs alleged that, although they had tested positive

for hepatitis C, defend ants failed to conduct followup liver

ass essments or refer them for specialized care. They sought2 Billy Dale Carter has also filed a motion for relief and

settlement memorandum which is unrelated to t he limited issues
p ending before this court related to plaintiff's claim for injunctive relief. The motion is therefore denied.

2 monetary damages and an order directing prison officials to provide

them with imm ediate treatment. While this suit was pending,

plainti ffs filed a number of motions. In one of these they

ass erted that prison officials had retaliated against them for

instituting suit and asked the district court to remove them from

state custody, or at least from the Dolph Briscoe Unit, for the

duration of the litigation. The magistrate judge determined that

plaintiffs ha d not alleged sufficient facts to support these

allegations. On his recommendation, the district court denied all

motions for injunctive relief. Plaintiff Carter filed this appeal.

This cour t will not reverse a district court's decision to

grant or deny a motion for a preliminary injunction absent a
showing of abuse of discretion. L akedreams v. Taylor
, 932 F.2d

1103, 1107 (5th Cir. 1991). The only fact offered to support

Carter's claim of retaliation is the timing of a major disciplinary

report filed against him; he was accused of threatening defendant

Waldrum only ten days after the p laintiffs served their

interrogatories. Presented with only this evidence, the district

court concluded that Carter had not demonstrated a substantial

threat that i rreparable injury would result from its failure to

grant an injunction. 2 The district court did not abuse its

discretion in so holding.

AFFIRMED.3
----

            DECISION OF THE EEA JOINT COMMITTEE         

No 98/2004

of 9 July 2004         

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

HAS DECIDED AS FOLLOWS:

Article 1

The following indent shall be added in point 15f (Council Directive 92/109/EEC) of Chapter XIII of Annex II to the Agreement:

Article 2

The texts of Directive 2003/101/EC in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 10 July 2004, provided that all the notifications under Article 103 (1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 9 July 2004.

For the EEA Joint Committee

The President

Kjartan JÓHANNSSON            

----

(1)OJ L 130, 29.4.2004, p. 3.

(2)OJ L 286, 4.11.2003, p. 14.

(*1)  No constitutional requirements indicated.

----
HomeOffice of the SpokespersonPublic Schedule...Public Schedule – May 28, 2024

# 									Public Schedule – May 28, 2024							

Public Schedule

Office of the Spokesperson

May 28, 2024

*****THE DAILY PUBLIC SCHEDULE IS SUBJECT TO CHANGE*****

 

**SECRETARY ANTONY J. BLINKEN**

Secretary Blinken is on travel to Moldova and Czechia from May 28-31, 2024.

**DEPUTY SECRETARY KURT M. CAMPBELL**

Deputy Secretary Campbell is on travel to Belgium from May 28-29, 2024.

**DEPUTY SECRETARY FOR MANAGEMENT AND RESOURCES RICHARD R. VERMA**

Deputy Secretary Verma is on travel to Colombia and Antigua and Barbuda from May 27-30, 2024.

**ACTING UNDER SECRETARY FOR POLITICAL AFFAIRS JOHN BASS**

Acting Under Secretary Bass has no public appointments.

**ASSISTANT SECRETARY FOR EUROPEAN AND EURASIAN AFFAIRS JAMES O’BRIEN**

Assistant Secretary O’Brien is on travel to Czechia from May 28-June 1, 2024.

**ASSISTANT SECRETARY FOR WESTERN HEMISPHERE AFFAIRS BRIAN A. NICHOLS**

Assistant Secretary Nichols is on travel to Antigua and Barbuda from May 27-30, 2024.

**ASSISTANT SECRETARY FOR POPULATION, REFUGEES, AND MIGRATION JULIETA VALLS NOYES**

Assistant Secretary Noyes is on travel to Colombia from May 27-30, 2024.

**BRIEFING SCHEDULE**

**1:15 p.m.**Department Press Briefing with Spokesperson Matthew Miller.**(OPEN PRESS COVERAGE)**

*The Department Press Briefing will be streamed live on the****Department homepage****and****YouTube Channel***.

Tags

Office of the SpokespersonSecretary TripThe Secretary of State

Back to Top
Certification 
 

I, Ann Murtlow, certify that:

1. I have reviewed this quarterly report on Form 10-Q of IPALCO Enterprises, Inc. (the"registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport; 

3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control over financialreporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant's auditors and the auditcommittee of registrant's board of directors (or persons performing the equivalentfunction):

(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant'sability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant's internal control over financial reporting.

Date:	December 13, 2005	
	/s/ Ann Murtlow	Ann MurtlowPresident and Chief Executive Officer
Exhibit 32.2

                      AXA EQUITABLE LIFE INSURANCE COMPANY

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Quarterly  Report on Form 10-Q for the  quarter  ended
September 30, 2006 of AXA Equitable  Life Insurance  Company (the  "Company") as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  I, Stanley B. Tulin,  Vice Chairman of the Board and Chief Financial
Officer of the Company,  certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


        (1) the Report fully complies with the  requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934, as amended; and

        (2) the  information  contained in the Report  fairly  presents,  in all
            material respects, the financial condition and results of operations
            of the Company.


                                        /s/ Stanley B. Tulin
                                        --------------------
                                        Stanley B. Tulin
                                        Vice Chairman of the Board and
                                        Chief Financial Officer
         Date: November 13, 2006
HomeOffice of the SpokespersonPublic Schedule...Public Schedule – February 20, 2023

# 									Public Schedule – February 20, 2023							

Public Schedule

Office of the Spokesperson

February 20, 2023

*****THE DAILY PUBLIC SCHEDULE IS SUBJECT TO CHANGE*****

 

**SECRETARY ANTONY J. BLINKEN**

Secretary Blinken is on travel to Germany, Türkiye, and Greece from February 16-22, 2023.

**8:30 a.m. LOCAL**Secretary Blinken meets with Turkish Foreign Minister Mevlut Cavusoglu in Ankara, Türkiye.**(POOLED CAMERA SPRAY AT TOP)**

**10:00 a.m. LOCAL**Secretary Blinken holds a joint press availability with Turkish Foreign Minister Mevlut Cavusoglu in Ankara, Türkiye.**(POOLED PRESS COVERAGE)**

**10:55 a.m. LOCAL**Secretary Blinken participates in a wreath laying ceremony at Anitkabir Mausoleum in Ankara, Türkiye.**(POOLED PRESS COVERAGE)**

**12:00 p.m. LOCAL**Secretary Blinken meets with Turkish President Recep Tayyip Erdogan in Ankara, Türkiye.**(CLOSED PRESS COVERAGE)**

**2:10 p.m. LOCAL**Secretary Blinken participates in a Chancery Dedication in Ankara, Türkiye.**(CLOSED PRESS COVERAGE)**

**3:00 p.m. LOCAL**Secretary Blinken holds a meet and greet for employees and families of U.S. Mission Türkiye in Ankara, Türkiye.**(CLOSED PRESS COVERAGE)**

**7:15 p.m. LOCAL**Secretary Blinken attends a working dinner with Greek Prime Minister Kyriakos Mitsotakis in Athens, Greece.**(POOLED CAMERA SPRAY AT TOP)**

Tags

Office of the SpokespersonSecretary TripThe Secretary of State

Back to Top
HomeAssisted Schools...Stavanger, Norway: International School of Stavanger: 2024 Special Needs Profile

# 									Stavanger, Norway: International School of Stavanger: 2024 Special Needs Profile							

Special Needs Profile

Office of Overseas Schools

February 22, 2024

## 								School Contact Information							

        -  Tel: +47-51-554-300 | Overseas Schools Fact Sheet | Regional Education Officer: Tim Stuart 
        -  E-mail: information@isstavanger.no | Website: www.isstavanger.no| Special needs information can be found at isstavanger.no/learning/learning-support. 
        -  Additional details on special needs support at post found on the **School Summary Information Portal**(must have OKTA login to access).  For more information, contact A/OPR/OS (**overseasschools@state.gov** / +1-202-261-8200), MED/CFP Child and Family Program Team (**MEDCFP@state.gov**/ +1-202-663-1815), or the school directly.    

**Download the Special Needs Profile** (Stavanger- 2024 Special Needs Profile- Norway [223 KB]) for this school to learn more about their capability to support students with exceptionalities.

The **International School of Stavanger**(ISS) is a coeducational, English-language, day school enrolling students ages three through 18+. The school was established in 1966. Approximately 80% of its students are from families associated with NATO and the North Sea oil industry. The school year extends from mid-August to mid-June. ISS is fully accredited by the New England Association of Schools and Colleges and holds membership with the Council of International Schools (CIS) and the Council of British International Schools (COBIS).

*This is intended to provide general information. Prospective users of the schools may wish to inquire further of A/OPR/OS or contact the school directly for more specific and up-to-the-minute information. Information and statistics are current as of December 2023 and provided by the school.*

NOTE: School situations can change quickly, particularly as schools face cutbacks to learning support programs due to the pandemic, unrest, and economic uncertainty. For the most current information, work with the REO and school. Information in this document was collected by the Department of State’s Office of Overseas Schools directly from the school in December 2023 and shows the availability of services rather than an assessment of the quality of the services. The profile is intended as a jumping off point for a conversation with the REO and school to understand the best fit for your child. Definitions may vary school to school.

Tags

NorwayOffice of Overseas Schools

Back to Top